GlucoTrack is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. Co. has developed a non-invasive glucose monitor, the GlucoTrack® glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings. The GlucoTrack utilizes a combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements via a sensor that is clipped onto one's earlobe and connected to a handheld control and display unit without drawing blood or interstitial fluid. We show 14 historical shares outstanding datapoints in our GCTK shares outstanding history coverage, used to compute GCTK market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing GCTK market cap history over the course of time is important for investors
interested in comparing GCTK's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of GCTK versus a peer is one thing; comparing
GCTK market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like GCTK can fluctuate over the course of history.
With this page we aim to empower investors researching GCTK by allowing them to research the GCTK market cap history. |
Free GCTK Email Alerts:
Video: The Importance of Market Cap
